Torrent Pharmaceuticals Ltd.
| BSE: 500420 | Sector: Health care |
| NSE: TORNTPHARM | ISIN Code: INE685A01028 |
| BSE 00:00 | 23 Oct | 2734.35 |
20.00 (0.74%) |
OPEN
2745.00 |
HIGH
2813.45 |
LOW
2722.00 |
| NSE 00:00 | 23 Oct | 2733.75 |
18.60 (0.69%) |
OPEN
2728.80 |
HIGH
2814.50 |
LOW
2716.00 |
| OPEN | 2745.00 |
| PREVIOUS CLOSE | 2714.35 |
| VOLUME | 14231 |
| 52-Week high | 3040.00 |
| 52-Week low | 1619.00 |
| P/E | 45.63 |
| Mkt Cap.(Rs cr) | 46,271 |
| Buy Price | 2734.35 |
| Buy Qty | 1.00 |
| Sell Price | 2746.00 |
| Sell Qty | 100.00 |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) - News Sector
-
Biocon posts 22% fall in Q2 net profit on high R&D expenses, staff costs
1.11 am | 24 Oct 2020 | Business Standard
The Bengaluru-headquartered company posted 10 per cent growth in consolidated revenue on a y-o-y basis to Rs 1,760 crore in Q2
-
Strong prospects of Biologics business keep Street positive on Biocon
10.24 pm | 23 Oct 2020 | Business Standard
Even though Q2 performance missed estimates, analysts expect a stronger second half
-
Dr Reddy's Laboratories shuts all units after cyber attack on servers
10.26 pm | 22 Oct 2020 | Business Standard
Security breach comes days after firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V
-
Aurobindo Pharma declines 6% on USFDA warning letter for Dayton facility
10.55 am | 22 Oct 2020 | Business Standard
The company said it would engage with the regulator and would try to resolve the issue at the earliest
-
Edelweiss's healthcare fund offers benefit of international diversification
12.24 am | 20 Oct 2020 | Business Standard
Allocation to a thematic offering like the newly-launched healthcare index fund should, however, be limited
-
Stock recommendation by Prabhudas Lilladher: Buy Hindalco, Aurobindo Pharma
7.51 am | 19 Oct 2020 | Business Standard
The RSI indicator for Hindalco Industries has recently indicated a decent rise to imply strength
-
Adani, Piramal, Oaktree and SC Lowy submit bids for troubled DHFL
12.50 am | 19 Oct 2020 | Business Standard
Oaktree bids for entire company, Piramal for retail loan book
-
Dr Reddy's: Progress in Covid vaccine trials to boost firm's growth outlook
1.12 am | 16 Oct 2020 | Business Standard
Good momentum in US and domestic sales, along with Covid-19 treatment portfolio is already driving analysts to upgrade earnings estimates
-
Kopran hits 52-week high after Crisil upgrades rating outlook to 'Positive'
2.01 pm | 13 Oct 2020 | Business Standard
The rating agency reaffirmed its 'CRISIL BBB' rating on long term bank facilities, while short term ratings has been reaffirmed at 'CRISIL A3+'
-
Pharma stocks gain; Cipla hits record high, Lupin nears 52-week high
12.53 pm | 13 Oct 2020 | Business Standard
In the past month, Cipla and Lupin outperformed the market by gaining 12 per cent each, against 8 per cent rise in Nifty Pharma index
-
Pharma stocks gain; Cipla hits record high, Lupin nears 52-week high
12.53 pm | 13 Oct 2020 | Business Standard
In the past month, Cipla and Lupin outperformed the market by gaining 12 per cent each, against 8 per cent rise in Nifty Pharma index
-
Stocks to watch: Infosys, SRF, Shalby, Voda Idea, RIL, Bharti Airtel, banks
8.52 am | 13 Oct 2020 | Business Standard
Here's a list of stocks that may trade actively in today's session.
-
PE firm PAG-led group to buy pharma firm Anjan Drug for undisclosed sum
10.51 pm | 12 Oct 2020 | Business Standard
Target company makes and supplies active pharmaeutical ingredients in the central nervous system space to some of the world's largest drug makers
-
Shilpa Medicare slips 12% on USFDA warning letter for Telangana facility
9.58 am | 12 Oct 2020 | Business Standard
The company believes that the warning letter will have minimum impact of disruption of supplies and the existing revenues from operations of this faci...
-
Here's a Bull Spread Strategy on Lupin by Nandish Shah of HDFC Securities
7.55 am | 9 Oct 2020 | Business Standard
Primary trend of the stock is positive where stock price is trading above its 200-day SMA
-
Cadila: Rebound in domestic formulations to add to US sales, drive earnings
12.40 am | 9 Oct 2020 | Business Standard
In the US, Cadila is expected to gain from improvement in realisation for its product range led by drug shortages
-
MARKET WRAP: Indices rise for 6th day; Sensex up 304 pts, reclaims 40K
4.28 pm | 8 Oct 2020 | Business Standard
All that happened in the markets today
-
Cipla up 5% on hope of healthy Q2 performance; rallies 56% in six months
3.22 pm | 8 Oct 2020 | Business Standard
The company is expected to report strong growth in the recently concluded quarter, driven by the portfolio of drugs it manufactures to combat Covid-19
-
Cadila Healthcare rises 4% on launch of pressurized Metered Dose Inhaler
10.48 am | 8 Oct 2020 | Business Standard
Forglyn pMDI is priced at Rs 495 per pack and has been developed in-house using Zydus' innovations in formulation technology
-
We can witness short covering if Nifty breaches 11,800: Gaurav Garg
8.09 am | 8 Oct 2020 | Business Standard
Nifty could face firm support in sub 11,600-zone.11,600 will act as support as maximum put OI is placed here
Quick Links for Torrent Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
